Cambridge Antibody Technology Group Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cambridge Antibody Technology Group

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jongmans who started this subject	10/28/2002 10:15:31 AM
From: aknahow	Read Replies (1) of 625

Not sure why other four "infringers" are kept confidential while CAT is named. Posted for curiosity value rather than significance. XOMA LTD /DE/ filed this 8-K/A on 10/24/2002. « Prev Page Outline Printer Friendly Entire Filing Next Page » -36- SCHEDULE 3.1(m) CERTAIN INTELLECTUAL PROPERTY MATTERS It is the Company's position that antibody discovery by phage display technology depends upon expressing antibody domains in bacteria as properly folded, functional, secreted proteins, as described in the Company's bacterial antibody expression patents, and that consequently companies engaging in antibody discovery using phage display without a license are infringing the Company's patents, particularly companies that provide phage display antibody discovery services to others, such as [], [], Cambridge Antibody Technology Limited, [], [] and [*].

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next